375.84
0.92 (0.25%)
| Penutupan Terdahulu | 374.91 |
| Jumlah Dagangan | 65,663 |
| Harga / Pendapatan (P/E Ke hadapan) | 40.88 |
| Harga / Jualan (P/S) | 3.90 |
| Harga / Buku (P/B) | 1.40 |
| Julat 52 Minggu |
| Margin Keuntungan | -85.16% |
| Margin Operasi (TTM) | 9.72% |
| EPS Cair (TTM) | -76.53 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -4.20% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -83.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 20.50% |
| Nisbah Semasa (MRQ) | 5.99 |
| Aliran Tunai Operasi (OCF TTM) | 515.30 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 250.23 M |
| Pulangan Atas Aset (ROA TTM) | 1.55% |
| Pulangan Atas Ekuiti (ROE TTM) | -27.52% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Bio-Rad Laboratories, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | -0.5 |
| Volatiliti Harga | -5.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | 2.2 |
| Persekitaran Makro | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | -0.57 |
|
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 16.14% |
| % Dimiliki oleh Institusi | 93.04% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Ariel Investments, Llc | 30 Jun 2026 | 816,751 |
| First Pacific Advisors, Lp | 30 Jun 2026 | 401,861 |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| DIVINCENZO JONATHAN P. | - | 369.95 | -951 | -351,822 |
| Jumlah Keseluruhan Kuantiti Bersih | -951 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -351,822 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 369.95 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| DIVINCENZO JONATHAN P. | Pegawai | 24 Oct 2026 | Dibuang (-) | 951 | 369.95 | 351,822 |
| DIVINCENZO JONATHAN P. | Pegawai | 24 Oct 2026 | Pelaksanaan pilihan | 1,869 | - | - |
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |